[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"ProVerum Medical\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":23,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":4},"100645393",false,"NCT07680543","ProVIDE Studies Post Exit Analysis","Inclusion Criteria:\n\n* 1\\. US based subjects previously enrolled in the ProVIDE Study or the ProVIDE II Bridging Study who had a ProVee device removed.\n* 2\\. Subjects who withdrew consent or were withdrawn by site Study PI.\n* 3\\. Subjects consented to make data available.\n\nExclusion Criteria:\n\n* 1\\. Incomplete records available.\n* 2\\. Subjects who exited the studies due to restarting BPH medication while they were enrolled.\n* 3\\. Subjects who did not receive a ProVee in the ProVIDE Study or the ProVIDE II Bridging Study.\n* 4\\. Subjects who exited the studies due to prostate cancer.","MALE","45 Years",{"count":17,"type":18},25,"ESTIMATED","OBSERVATIONAL","A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.",[22],"BPH With Symptomatic Lower Urinary Tract Symptoms",[24],"BPH \u002F LUTS","NOT_YET_RECRUITING","2026-06-25",{"date":28,"type":29},"2026-07-02","ACTUAL",{"date":31,"type":18},"2026-07-14",{"date":33,"type":18},"2029-07-31",{"name":35,"class":36},"ProVerum Medical","INDUSTRY",""]